HomeHypertensionVol. 54, No. 3Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBAdrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling Masayuki Tanemoto, Eikan Mishima, Yoichi Takeuchi and Takaaki Abe Masayuki TanemotoMasayuki Tanemoto Division of Nephrology, Hypertension, and Endocrinology, Department of Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan Search for more papers by this author , Eikan MishimaEikan Mishima Division of Nephrology, Hypertension, and Endocrinology, Department of Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan Search for more papers by this author , Yoichi TakeuchiYoichi Takeuchi Division of Nephrology, Hypertension, and Endocrinology, Department of Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan Search for more papers by this author and Takaaki AbeTakaaki Abe Division of Nephrology, Hypertension, and Endocrinology, Department of Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan Search for more papers by this author Originally published20 Jul 2009https://doi.org/10.1161/HYPERTENSIONAHA.109.137141Hypertension. 2009;54:e23Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: July 20, 2009: Previous Version 1 To the Editor:We read with interest the article by Seccia et al,1 which investigated the effect of adrenocorticotropic hormone stimulation during adrenal vein sampling on the identification of lateralized aldosterone excess in primary aldosteronism. The authors concluded that a high or an intermediate dose of adrenocorticotropic hormone stimulation lowered the correct identification of the aldosterone-producing adenoma (APA) side. However, the cases with the lowered identification by the stimulation might have been the cases with bilateral aldosterone excess. Reduction of blood pressure (BP) and plasma aldosterone concentration after adrenalectomy could not exclude the possibility of bilateral aldosterone excess.2Several APAs are difficult to detect on computed tomography and magnetic resonance findings, and these small APAs would not be rare.3 In the case with a small APA in the adrenal gland contralateral to the resected side, the remaining APA would retain aldosterone excess, which could result in poor BP reduction after unilateral adrenalectomy. From the BP response to adrenalectomy in the cases of Seccia et al,1 we suspect that several of them might have had small APAs in the contralateral sides. Furthermore, in some cases, the plasma aldosterone concentration after adrenalectomy remained at >12.1 ng/dL (the value taken for aldosterone excess before adrenalectomy), presumed from its values (median: 10.1; range: 2.3 to 15.8 ng/dL). We suspect that these cases might have been the cases with lowered identification by the stimulation. Reduction of BP and plasma aldosterone concentration after adrenalectomy should be compared between the cases with and without the lowered identification. If the cases with the lowered identification had poor BP and plasma aldosterone concentration reduction, the adrenocorticotropic hormone–stimulated adrenal vein sampling would be preferable to the unstimulated one for the identification of lateralized aldosterone excess in primary aldosteronism.4DisclosuresNone.1 Seccia TM, Miotto D, De Toni R, Pitter G, Mantero F, Pessina AC, Rossi GP. Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols. Hypertension. 2009; 53: 761–766.LinkGoogle Scholar2 Sukor N, Gordon RD, Ku YK, Jones M, Stowasser M. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab. 2009; 94: 2437–2445.CrossrefMedlineGoogle Scholar3 Rossi GP, Sacchetto A, Chiesura-Corona M, De Toni R, Gallina M, Feltrin GP, Pessina AC. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab. 2001; 86: 1083–1090.CrossrefMedlineGoogle Scholar4 Tanemoto M, Suzuki T, Abe M, Abe T, Ito S. Physiological variance of corticotropin affects diagnosis in adrenal vein sampling. Eur J Endocrinol. 2009; 160: 459–463.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Bardet S, Chamontin B, Douillard C, Pagny J, Hernigou A, Joffre F, Plouin P and Steichen O (2016) SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis, Annales d'Endocrinologie, 10.1016/j.ando.2016.01.008, 77:3, (208-213), Online publication date: 1-Jul-2016. Wolley M, Gordon R, Pimenta E, Daunt N, Slater G, Ahmed A and Stowasser M (2013) Repeating adrenal vein sampling when neither aldosterone/cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma, Journal of Hypertension, 10.1097/HJH.0b013e328362add3, 31:10, (2005-2009), Online publication date: 1-Oct-2013. September 2009Vol 54, Issue 3 Advertisement Article InformationMetrics https://doi.org/10.1161/HYPERTENSIONAHA.109.137141PMID: 19620508 Originally publishedJuly 20, 2009 PDF download Advertisement